Overall survival (OS) |
|
|
|
|
Progression free survival (PFS) |
|
|
|
|
Event free survival (EFS) |
|
|
|
|
Time to next treatment (TTNT) |
|
|
|
|
Time to progression (TTP) |
|
|
|
|
Progression of disease in 24 months (POD24) |
|
|
|
|
Progression free survival in 24 months (PFS24) |
|
|
|
|
Minimal residual disease (MRD) |
|
|
|
|
Complete response at 30 months (CR30) |
|
|
|
|